Literature DB >> 18959400

Quantitative three dimensional structure linear interaction energy model of 5'-O-[N-(salicyl)sulfamoyl]adenosine and the aryl acid adenylating enzyme MbtA.

Nicholas P Labello1, Eric M Bennett, David M Ferguson, Courtney C Aldrich.   

Abstract

MbtA (a salicyl AMP ligase) is a key target for the design of new antitubercular agents. On the basis of structure-activity relationship (SAR) data generated in our laboratory, a structure-based model is developed to predict the binding affinities of aryl acid-AMP bisubstrate inhibitors of MbtA. The approach described takes advantage of the linear interaction energy (LIE) technique to derive linear equations relating ligand structure to function. With only two parameters derived from molecular dynamics simulations, good correlation (R(2) = 0.70) was achieved for a set of 31 inhibitors with binding affinities spanning 6 orders of magnitude. The results were applied to understand the effect of steric and heteroatom substitutions on bisubstrate ligand binding and to predict second generation inhibitors of MbtA. The resulting model was further validated by chemical synthesis of a novel inhibitor with a predicted LIE binding affinity of 1.6 nM and a subsequently determined experimental K(i)(app) of 0.7 nM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18959400      PMCID: PMC2869039          DOI: 10.1021/jm800668u

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

Review 1.  Genetics and assembly line enzymology of siderophore biosynthesis in bacteria.

Authors:  Jorge H Crosa; Christopher T Walsh
Journal:  Microbiol Mol Biol Rev       Date:  2002-06       Impact factor: 11.056

2.  Linear Interaction Energy (LIE) Models for Ligand Binding in Implicit Solvent:  Theory and Application to the Binding of NNRTIs to HIV-1 Reverse Transcriptase.

Authors:  Yang Su; Emilio Gallicchio; Kalyan Das; Eddy Arnold; Ronald M Levy
Journal:  J Chem Theory Comput       Date:  2007-01       Impact factor: 6.006

3.  An augmented effective core potential basis set for the calculation of molecular polarizabilities.

Authors:  Nicholas P Labello; Antonio M Ferreira; Henry A Kurtz
Journal:  J Comput Chem       Date:  2005-11-15       Impact factor: 3.376

4.  Rationally designed nucleoside antibiotics that inhibit siderophore biosynthesis of Mycobacterium tuberculosis.

Authors:  Ravindranadh V Somu; Helena Boshoff; Chunhua Qiao; Eric M Bennett; Clifton E Barry; Courtney C Aldrich
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

5.  Inhibition of siderophore biosynthesis by 2-triazole substituted analogues of 5'-O-[N-(salicyl)sulfamoyl]adenosine: antibacterial nucleosides effective against Mycobacterium tuberculosis.

Authors:  Amol Gupte; Helena I Boshoff; Daniel J Wilson; João Neres; Nicholas P Labello; Ravindranadh V Somu; Chengguo Xing; Clifton E Barry; Courtney C Aldrich
Journal:  J Med Chem       Date:  2008-12-11       Impact factor: 7.446

6.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density.

Authors: 
Journal:  Phys Rev B Condens Matter       Date:  1988-01-15

7.  The EntF and EntE adenylation domains of Escherichia coli enterobactin synthetase: sequestration and selectivity in acyl-AMP transfers to thiolation domain cosubstrates.

Authors:  D E Ehmann; C A Shaw-Reid; H C Losey; C T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

8.  Design, synthesis, and biological evaluation of beta-ketosulfonamide adenylation inhibitors as potential antitubercular agents.

Authors:  Jagadeshwar Vannada; Eric M Bennett; Daniel J Wilson; Helena I Boshoff; Clifton E Barry; Courtney C Aldrich
Journal:  Org Lett       Date:  2006-10-12       Impact factor: 6.005

Review 9.  Targeting iron acquisition by Mycobacterium tuberculosis.

Authors:  Ryan R Monfeli; Craig Beeson
Journal:  Infect Disord Drug Targets       Date:  2007-09

Review 10.  Enterobactin: an archetype for microbial iron transport.

Authors:  Kenneth N Raymond; Emily A Dertz; Sanggoo S Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

View more
  5 in total

Review 1.  Adenylating enzymes in Mycobacterium tuberculosis as drug targets.

Authors:  Benjamin P Duckworth; Kathryn M Nelson; Courtney C Aldrich
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

2.  Synthesis of chromone, quinolone, and benzoxazinone sulfonamide nucleosides as conformationally constrained inhibitors of adenylating enzymes required for siderophore biosynthesis.

Authors:  Curtis A Engelhart; Courtney C Aldrich
Journal:  J Org Chem       Date:  2013-07-12       Impact factor: 4.354

Review 3.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery.

Authors:  Sean Ekins; Joel S Freundlich; Inhee Choi; Malabika Sarker; Carolyn Talcott
Journal:  Trends Microbiol       Date:  2010-12-02       Impact factor: 17.079

4.  Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis.

Authors:  Kathryn M Nelson; Kishore Viswanathan; Surendra Dawadi; Benjamin P Duckworth; Helena I Boshoff; Clifton E Barry; Courtney C Aldrich
Journal:  J Med Chem       Date:  2015-07-09       Impact factor: 7.446

5.  Biochemical and structural characterization of bisubstrate inhibitors of BasE, the self-standing nonribosomal peptide synthetase adenylate-forming enzyme of acinetobactin synthesis.

Authors:  Eric J Drake; Benjamin P Duckworth; João Neres; Courtney C Aldrich; Andrew M Gulick
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.